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persons 40 years and older and 3 in 100 persons 80 years and older. 1 Its incidence increases steeply with advancing age. 2, 3 The total US population 65 years and older is projected to increase to approximately 80 million by the year 2050. Most rapidly growing, however, is the age group 85 years and older, which is projected to double in size from 1990 to 2020 and to increase 6-fold by the year 2050. 4 The increasing number of elderly people, in particular the oldest old, implies a growing number of people at risk for PD. Therefore, the effect of PD on health care and its cost to society are expanding continuously.
Few studies have addressed the cost of and utilization of health care services for PD, and limited data are available on the effect of such services on disease outcome. [5] [6] [7] [8] [9] [10] The aims of this study were (1) to compare a population-based sample of incident PD patients with a group of age-and sex-matched reference subjects from the same population with regard to survival, nursing home placement, and utilization of medical services and (2) to identify demographic and clinical factors that affect disease outcomes.
PATIENTS AND METHODS General Study Design
The present study was designed as a historical cohort study, including a cohort of patients with PD and a reference cohort of subjects without PD. The cohort of incident PD patients was identified by using the medical records linkage system of the Rochester Epidemiology Project. Olmsted County, Minnesota, residents without PD were matched by age, sex, and time in the system and were used as reference subjects. In the data analyses, PD was consid-ered the independent variable, and survival, nursing home placement, and several measures of health care utilization were the dependent variables.
PD Cases
A cohort that included all 89 incident cases of PD in Olmsted County during the 10-year period 1979 through 1988 was identified through the medical records linkage system of the Rochester Epidemiology Project as part of a previous study. 2 The following diagnostic criteria for PD were used: (1) presence of 3 of the 4 cardinal signs of parkinsonism (ie, rest tremor, bradykinesia, rigidity, and postural reflex impairment), presence of 2 of the cardinal signs and diagnosis of typical PD by a neurologist, or presence of 2 of the cardinal signs and improvement of symptoms with antiparkinsonian therapy (as documented in the medical record); (2) no other apparent cause of parkinsonism; and (3) absence of signs of more extensive nervous system dysfunction (not expected in PD). 2 In particular, cases of parkinsonism with evidence of dementia preceding or within the first year of motor symptoms were excluded. As per the second criterion, we also excluded cases of parkinsonism with a preceding exposure to neuroleptics that was temporally related to the onset of symptoms (cases of drug-induced parkinsonism). In the original incidence study of PD, 43 potential cases identified through the records linkage system were excluded because they did not fulfill the criteria for PD. 2 Of the 95 cases included in the original incidence study, we excluded 6 additional cases for the following reasons: 1 because onset of PD was before the incidence period, 1 because the patient was not a county resident at onset, and 4 because subsequent autopsy study excluded the diagnosis of PD.
Reference Subjects
The records linkage system was used to match 1 population subject without PD to each case by age, sex, and year of first medical registration with the system. The following criteria were used for reference subject selection: (1) resident of Olmsted County in the index year (ie, the year of PD onset in the matched case) and (2) no diagnosis of PD or other type of parkinsonism before the index year, in the index year, or during the follow-up period of this study. The presence of neurologic diseases other than parkinsonism was not an exclusion criterion; therefore, reference subjects with dementia, for example, were included. In the selection of reference subjects, only 15 candidates were excluded for the following reasons: 7 were affected by parkinsonism, 1 had insufficient documentation to exclude parkinsonism, 3 were not residents of Olmsted County in the index year, and 4 migrated into or out of the county during the index year.
Data Collection
The complete medical dossiers of PD patients and reference subjects in the records linkage system were reviewed to abstract information about medical services utilization and outcomes. For cases, we defined the index year as the year of onset of PD symptoms (ie, the year in which the patient or a physician observed for the first time rest tremor, bradykinesia, or rigidity). 2 Because it was difficult to determine the exact date of symptom onset, we arbitrarily used July 1 as the reference date for computations. For reference subjects, the index year was the year of onset of PD in the matched case.
The following disease characteristics were recorded for PD patients: presence or absence of tremor at the time of symptom onset or at the time of diagnosis, response to dopaminergic medications as previously described (no or minimal improvement vs more than minimal improvement), 11 and presence or absence of dementia at any time during the follow-up period. Using a previously described definition, a diagnosis of dementia required fulfillment of 3 criteria: (1) evidence of previously normal intellectual and social function, irreversible decline in intellectual and social function, dementia as a predominant symptom, and definite evidence of memory impairment; (2) at least 2 of the following symptoms (patient must be fully alert): disorientation, decline in personality and/or behavior, dyscalculia, apraxia and/or agnosia, problems with language, and/or impairment in judgment and/or abstract thinking; and (3) cognitive impairment lasting at least 6 months. 12 Selected utilization data were abstracted for PD patients and corresponding reference subjects separately for the 5 years preceding the index year, the index year, and the period from January 1 of the year following the index year until the earliest of the following events: last contact with the system, death, or the end of the study (July 1, 1995) . Utilization data for the 5-year period predating the index year and for the index year were collected to provide baseline information regarding access to health care services and utilization patterns for the 2 groups and to account for possible utilizations as a result of prodromal PD. The numbers of physician consultations, emergency department visits, orthopedic procedures, physical or occupational therapy visits, inpatient days, and intensive care unit days were recorded separately for these 3 periods. Physician consultations included primary care consultations, physician visits at the nursing home, and other specialty consultations (including neurology). Neurology consultations were also recorded separately for PD patients. Information regarding permanent nursing home placement and date of nursing home admission and treatment with antidepressants, neuroleptics, or benzodiazepines for at least 1 month was also abstracted. Only medications used after the year of onset of PD for patients or after the index year for reference subjects were considered.
Data Analysis
We compared PD patients and reference subjects with respect to the number of physician consultations, hospital days, intensive care unit days, emergency department visits, orthopedic procedures, and physical or occupational therapy visits. For each subject, we computed an average number of encounters or an average number of utilization days per year (dividing the total number of encounters or days by the total number of years of follow-up). Nonparametric methods were used for data description and hypothesis testing because much of the data were highly skewed. Similar analyses were performed also for the 5 years preceding the index year and the index year. Additional univariate analyses were performed after stratification by age at index year (stratified in decades), sex, marital status (married vs never married, widowed, or divorced), and education (less than high school vs higher education) as explanatory variables. Continuous variables were compared using the rank sum test, whereas dichotomous variables were compared using the χ 2 test. Univariate analyses were supplemented with multivariate regression analyses by using the same explanatory variables (linear regression for continuous outcome variables and logistic regression for dichotomous outcome variables; steppingdown approach).
Life table methods were used to evaluate survival (time from onset or index year to death) and time to permanent nursing home placement. Kaplan-Meier curves and log rank tests were used for univariate analyses. Cox proportional hazards models were used for multivariate analyses. Analyses were repeated after restricting the sample to the cohort of PD patients (case-case comparison) and including 3 additional independent variables: presence of tremor (at onset), dementia (at any time), and response to levodopa (at any time). The last 2 variables were treated as time-dependent covariates in Cox proportional hazards models. These case-case comparisons were conducted to further identify subgroups of PD patients with differing prognosis and patterns of utilization.
All statistical tests were 2-tailed at the conventional α level of .05. Table 1 shows the distributions of age at PD onset (median, 73 years; range, 48-88 years) and sex (58.4% were men and 41.6% women). Median age at PD onset was 70 years for men (range, 48-86 years) and 78 years for women (range, 55-88 years). Both the age and the sex distribution were identical for the reference group by virtue of matching. Table 2 contains information on marital status and education level for both groups and on disease characteristics for the PD group. The median duration of followup was 7.0 years for patients (range, <1-15.5 years) and 7.5 years for controls (range, <1-15.5 years).
RESULTS

Demographic and Disease Characteristics
Utilization of Medical Services
The 2 groups did not differ in utilization of medical services before and during the index year, with the sole exception of physical or occupational therapy visits, which were significantly more frequent in the reference group. During the follow-up period, there was a clear trend toward increased utilization of medical services by PD patients, which attained statistical significance for physician consultations and emergency department visits (Table 3) . Within the PD cohort (case-case comparison), the multivariate model revealed that patients with good response to dopaminergics and patients with at least a high school education had more frequent physician encounters in general (P=.006 for both variables), whereas younger patients had more frequent neurologic consultations (P<.001). Patients with at least a high school education had more physical or occupational therapy visits (P=.04).
Regarding the use of psychoactive medications after the index year, there was no appreciable difference in the use of benzodiazepines between PD patients and reference subjects, whereas patients with PD were more likely to use antidepressants and neuroleptics (Table 4) . Increased use of antidepressants and neuroleptics by PD patients, compared with reference subjects, applied both to PD patients with tremor at onset (relative risk [RR], 3.6; 95% confidence interval [CI], 1.7-7.5; P<.001 for antidepressants; RR, 4.0; 95% CI, 1.5-11.1; P=.007 for neuroleptics) and to PD patients with an akinetic-rigid presentation (RR, 2.5; 95% CI, 1.1-6.0; P=.03 for antidepressants; RR, 4.8; 95% CI, 1.6-15.2; P=.006 for neuroleptics). There was no significant difference between the 2 subtypes of PD. Finally, married PD patients were less likely to be treated with antidepressants than never married, widowed, or divorced PD patients (RR, 0.3; 95% CI, 0.1-0.8;
P=.01).
Nursing Home Placement Figure 1 , left graph, compares the length of independent living for the 2 groups after the index year. Patients with PD were placed in nursing homes earlier than reference subjects (RR, 6.7; 95% CI, 3.7-12.1; P<.001). At univariate analysis within the PD cohort (case-case comparison), late placement (ie, a longer time between onset of PD and institutionalization) was associated with good response to dopaminergics (RR, 0.5; 95% CI, 0.3-0.9; P=.02) and completion of high school or higher education (RR, 0.5; 95% CI, 0.3-0.9; P=.02). Early placement (ie, a shorter time between onset of PD and institutionalization) was associated with older age at onset (age at onset in decades: RR, 3.1; 95% CI, 2.0-4.4; P<.001) and with presence of dementia (RR, 2.3; 95% CI, 1.2-4.4; P=.01). Multivariate Cox proportional hazards models revealed no predictors of early placement other than older age at onset (age at onset in decades: RR, 3.4; 95% CI, 2.4-4.8; P<.001).
Survival Figure 1 , right graph, compares survival after the index year for the 2 groups. Patients with PD had shorter survival than reference subjects (RR, 2.2; 95% CI, 1.
4-3.4; P<.001).
At univariate analysis within the PD cohort (case-case 
DISCUSSION
This study provides data on the utilization of medical services and disease outcomes in a population-based incidence cohort of PD patients and matched reference subjects with appreciable longitudinal follow-up. The comprehensive medical records linkage system serving Olmsted County provided complete and detailed utilization data. Our study identified demographic and disease characteristics that may influence the utilization of medical services by patients with PD and that may predict their outcome. This knowledge can be applied to design further studies on the effect of specific medical services on disease prognosis. Moreover, such information can promote medical practices that will improve care for PD patients.
Weaknesses of this study include the relatively small size of the population, which necessitated extending the study of incidence over a 10-year period. The patterns of medical services utilization changed over time as new therapeutic approaches emerged; therefore, utilization data may not be comparable over such long periods. In addition, our findings refer to a well-defined county with some unique medical practice characteristics. Any inferences or extrapolations of our findings to other populations in the United States or abroad are based on judgment and should consider differences in ethnic composition and socioeconomic status. Because of the limited size of the PD patient population, only a small number of variables could be analyzed with sufficient statistical power. A similar study of prevalent rather than incident cases of PD may have provided a larger sample but would have been hampered by survival bias and would have overrepresented patients with less severe forms of the disease.
Another weakness of the study is the possibility that some of our cases of PD were misclassified since diagnostic criteria were applied retrospectively at record review by a movement disorders specialist. We cannot exclude that some of the cases diagnosed as PD were actually affected by progressive supranuclear palsy, dementia with Lewy bodies, or another type of parkinsonism. However, possible misclassification is common to any study based on a clinical definition of PD and could not be eliminated in our study. Finally, we cannot exclude that access to the medical services of the records linkage system varied by age, sex, socioeconomic status, and other factors that may have introduced bias in our comparisons of cases and reference subjects.
Previously identified predictors of increased utilization among PD patients included the following: disease severity, [5] [6] [7] [8] [9] [10] akinetic-rigid disease subtype, 6,7 disease managed primarily by a neurologist, 8 and socioeconomic factors. 10 The most important contributor to the cost of the disease was shown to be hospitalization, [5] [6] [7] [8] [9] followed by ancillary services 8, 9 and drugs. 8 Our findings suggest that patients with PD use certain medical services more frequently than persons without PD of the same age and sex. Patients with PD consulted with a physician, visited the emergency department, were admitted to a nursing home, and used antidepressant and neuroleptic medications more frequently than their matched reference subjects. Previous studies have suggested that patients with PD may differ from the general population with regard to comorbid conditions. Gorell et al 13 found PD patients more susceptible to cerebrovascular disease and pneumonia and less likely to die of cancer compared with the general population. Ben-Shlomo and Marmot 14 reported increased frequency of both ischemic heart and cerebrovascular disease as causes of death among PD patients. Such differences in comorbidity may account in part for the increased utilization of medical services among PD patients in our study. However, the similar utilization frequencies of cases and reference subjects in the 5 years preceding the index year and during the index year favor PD (and not comorbidities) as the primary reason for the observed increased utilization.
Our finding that patients with good response to dopaminergic medications had a greater number of physician consultations may reflect the need for dosage adjustment, management of complications, and higher perceived value of such visits on the part of the patient. Increased use of health care services among patients with higher education may reflect better access to health care and better compliance with and appreciation of medical intervention. The greater number of neurologic consultations among younger vs older patients may reflect a specialty referral bias favoring younger patients. Vieregge et al 15 also noted that in Germany younger patients were more likely to receive care from a neurologist, whereas older patients usually received care from a general practitioner. Roos et al 16 reported that men and patients with tremor as their presenting symptom of PD sought medical attention earlier in their disease than women and patients without tremor at onset. By contrast, we observed no association between sex or disease subtype and services utilization.
Increased use of antidepressant and antipsychotic medication has been reported in hospitalized PD patients in the United Kingdom 17 ; however, a study of antidepressant use among elderly patients in the Netherlands 18 did not identify PD as a predictor of antidepressant use. Such apparent discrepancies may arise from differences not only in study design but also in the standard of clinical practice in different countries. One interesting finding in our study was the relatively lower use of antidepressants among married patients, which emphasizes the role of a family support system in the overall well-being of PD patients. We were surprised by the high frequency of administration of neuroleptic drugs to PD patients in our historical cohort because these drugs are known to block the dopamine receptors and to exacerbate PD. This use may reflect the high frequency of dementia in our cases and the resulting need to treat behavioral problems and behavioral adverse effects of dopaminergic medications. Because our study covered the period between 1979 and 1995, alternative treatments for behavioral problems, such as selective antipsychotic agents (eg, clozapine or quetiapine), were not available.
Permanent nursing home placement can be viewed as either a measure of health care utilization or a prognostic measure. Few data on nursing home placement in PD exist in the literature. Woo et al 19 identified PD as a risk factor for nursing home placement among elderly patients in Hong Kong, whereas Vieregge et al 15 reported that 19% of a cross-sectional series of patients with parkinsonism were in a nursing home. Mitchell et al 20 reported a PD prevalence of 6.8% among 5020 nursing home residents older than 55 years. Institutionalized PD patients were comparatively younger, more frequently men, more severely motor impaired, more dependent in activities of daily living, more likely depressed, and usually taking more medications compared with other nursing home residents. That study 20 failed to show an increased mortality in the PD group. Goetz and Stebbins, 21 however, found increased mortality among institutionalized PD patients compared with age-, sex-, and disease duration-matched PD patients living independently. The same investigators identified the presence of hallucinations or delusions as the sole risk factor for nursing home placement in a study of 11 institutionalized PD patients. 22 A more recent Norwegian study 23 also concluded that hallucinations were the strongest predictor of nursing home placement of patients with PD.
Berger et al 24 reviewed the results of several European studies of institutionalization of patients with PD. They concluded that PD patients were overall 4.6 times more likely to live in a care facility compared with the rest of the community. Women were placed in a care facility 5 times more often than men. Older age also seemed to increase risk for institutionalization. 24 Our findings are consistent with these European findings. Moreover, we identified older age at PD symptom onset, presence of dementia, lack of good response to dopaminergic medications, and lower education level (<12 years) as additional risk factors for nursing home placement.
Many studies have addressed survival in PD. The increased RR of death in PD patients found in this study correlates well with the estimates reported in the literature both in the United States 11,25-27 and abroad. 14, 24, [28] [29] [30] Various risk factors have been identified for reduced survival among PD patients, including older age at onset, presence of dementia, advanced Hoehn and Yahr stage, postural disturbance, and poor response to levodopa. There have been contradictory reports regarding sex differences. Our results agree with the literature implicating poor response to dopaminergic medications, older age at PD symptom onset, and presence of dementia as potential risk factors for reduced survival times in PD; however, they do not support an association between sex and survival in PD. The improved survival times noted among PD patients with high school or higher education may reflect the increased utilization of medical services among these patients, which was also observed in this study.
The association of disease subtype at presentation with disease outcome merits special mention. Although the presence of tremor at onset has been reported to be associated with improved clinical course in motor and cognitive function, 31 our study showed no better prognosis for this subgroup of PD patients regarding either survival or permanent nursing home placement.
Our findings have clinical implications. First, physicians should consider the prognostic factors for nursing home placement and survival identified in this study when evaluating patients for surgical treatments of PD (ie, they may exclude patients with poor prognosis). Second, physicians should avoid the use of antidopaminergic drugs, such as neuroleptics, in patients with PD. This practice is clearly outdated with the advent of atypical antipsychotic drug therapies (eg, clozapine or quetiapine).
